At the recent SEC meeting for endocrinology and metabolism, the expert panel reviewed the proposal along with the ...

The UK’s NHS Business Services Authority's annual 'Prescribing for Diabetes - England 2015/16 to 2024/25' report reveals that diabetes treatments now account for 15% of all NHS prescription spending, ...

The decision comes after evidence suggested these drugs protect the heart and kidneys as well as controlling blood sugar, ...

Today’s announcement (August 20) on draft guidelines from the UK’s National Institute for Health and Care Excellence (NICE) ...

GPs could face a rise in prescribing and monitoring work under draft NICE guidelines recommending earlier use of newer type 2 ...

The NHS should move away from a one-size-fits-all approach of starting everyone on the same medication, to more personalised care that aims to prevent complications like heart failure and heart ...

The change from the National Institute for Health and Care Excellence will be the most significant for a decade ...

Lilly is on track to file its oral GLP-1 agonist orforglipron for type 2 diabetes next year after presenting the first phase 3 data with the drug.